ANDA 215403, held by Inforlife. Acetaminophen.
As of Nov 13, 2026, ANDA 215403 (Acetaminophen), held by Inforlife, was first approved by FDA on May 3, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 3, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Acetaminophen1GM/100ML (10MG/ML) ยท solution;intravenous | Acetaminophen | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
